Basic laboratory research has fueled many advances in cancer diagnosis, prevention and care. By revealing the nature of specific cancers and unlocking their mysteries, basic science has led to the development of more effective cancer therapies, earlier and better detection methods and improved outcomes for cancer patients everywhere.
We know that to effectively diagnose and treat cancers, we must understand the biology underlying their development. To that end, MD Anderson established the Institute for Basic Science (IBS) in 2008. Its goal is to accelerate scientific discoveries in a collaborative environment that maximizes individual and collective success. Encompassing MD Anderson’s traditional basic science departments, from biochemistry and molecular biology to veterinary sciences, the IBS also comprises seven multidisciplinary centers of research excellence. Interactive teams at the IBS focus on cutting-edge work in cancer genetics, epigenetics, inflammation, carcinogenesis, molecular structures, cell-to-cell signaling, stem cell biology and more.
We are grateful to those who are committed to MD Anderson’s mission of eliminating cancer by contributing to the creation and continued growth of the IBS. With your philanthropic support, we are building on MD Anderson’s world-class research strengths and forging new paths of discovery that will directly benefit cancer patients now and for generations to come. Thank you for joining us in Making Cancer History®.